Canada · Delayed Price · Currency is CAD Auxly Cannabis Group Earnings Call Transcripts
Fiscal Year 2026
-
Record Q2 2026 results with 18% revenue growth, 31% EBITDA margin, and strong cash flow conversion. Continued innovation and operational efficiency drive profitability, while a disciplined capital program and share repurchases support long-term growth.
-
A leading Canadian cannabis producer reported strong financial growth, with record Q1 2026 results, expanding market share, and industry-leading margins. Innovation, operational scale, and a strategic global partnership position the company for continued domestic and international expansion.
-
Q1 2026 saw record net revenue and profitability, driven by strong demand for flower and pre-rolls, with Back Forty leading the market. Gross margin improved to 55%, and the company expects to outperform industry growth in 2026 while maintaining disciplined capital allocation.
Fiscal Year 2025
-
Record 2025 results included 24% revenue growth, 54% gross margin, and 64% higher adjusted EBITDA. Continued profitability and cash flow are expected, with investments in capacity, innovation, and selective M&A. Consumer demand is strong, with value and quality driving brand leadership.
-
A leading Canadian cannabis producer reported record Q3 2025 results, driven by strong sales, operational efficiency, and product innovation. With a robust balance sheet and strategic partnership, the company is poised for continued domestic growth and selective international expansion.
-
A leading Canadian cannabis producer reported record Q2 results, driven by strong brand performance, innovation in pre-rolls and vapes, and operational efficiency. Recent recapitalization improved financial flexibility, with a focus on profitable, capital-light growth.